Similarly, the advanced lung cancer inflammation index (ALI), which is a modification of NLR that includes albumin (ALB) and body mass index (BMI), has been developed and demonstrated to be a prognostic marker of poor survival in several cancers, including non-small cell lung cancer (NLSCL) (Jafri et al., 2013). Here, ALB is linked to non-small cell lung carcinoma.